⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
National AIDS Memorial Marks World AIDS Day with Two Signature Events Highlighting the Power of Communities to Shape Progress in the Fight Against HIV/AIDS and Advance Health and Social Justice
businesswire.com
GILD
TROP-2-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025: Market Opportunities with High Trop-2 Expression in Multiple Aggressive Cancers Like Breast and Bladder - ResearchAndMarkets.com
businesswire.com
GILD
Cystic Fibrosis Therapeutics Market Set to Reach USD 35.09 Billion by 2033 as Precision CFTR Modulator Therapies Transform Patient Outcomes
prnewswire.com
VRTX
RHHBY
NVS
TEVA
GILD
Blood Cancer United Showcases Bold Research and Vision at 2025 ASH Annual Meeting
prnewswire.com
ABBV
GILD
BMY
REGN
XBI
Five Years Left: Business Coalition Marks World AIDS Day With 550+ Commitments To End HIV by 2030
prnewswire.com
GILD
VIV
WBA
CHV
MTCH
CVS
PARA
AVTA
THRX
CAR T-Cell Therapy for the Multiple Myeloma Market, 2025-2035: Extensive Data on Products, End Users, Regions and Companies - ResearchAndMarkets.com
businesswire.com
BMY
JNJ
NVS
GILD
U.S. CAR T-Cell Therapies Market Grows at 30.4% CAGR, Soars USD 42.61 Billion by 2035
globenewswire.com
BIIB
GILD
BMY
ABBV
MRNA
CRSP
NTLA
EDIT
Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035
globenewswire.com
PFE
AZN
DSNKY
GILD
IMMU
REGN
BIIB
BMY
MRK
NVS
AMGN
LLY
JNJ
ABBV
BNTX
SEGN
RHHBY
Takeda
IQV
PE
TROP-2-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025: Approved Therapies Trodelvy and Datroway Showcase Commercial Success and Clinical Validation
globenewswire.com
GILD
Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors
globenewswire.com
VERA
GILD
SANG
CTMX